Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Chronic Myeloproliferative Disorder Gene Panel (CMPD) test is 14 days.

What are the prerequisites for the test Chronic Myeloproliferative Disorder Gene Panel (CMPD)

  • Patient must have a suspected or confirmed diagnosis of chronic myeloproliferative disorder
  • Physician's order
  • Specimen type: blood
  • Specimen volume: 5-10 mL
  • Specimen container: lavender top (EDTA) tube
  • Specimen stability: stable at room temperature for up to 72 hours
  • Specimen must be received within 7 days of collection

What are the measure values for the test Chronic Myeloproliferative Disorder Gene Panel (CMPD)

Gene Panel Name Measure Values
Chronic Myeloproliferative Disorder Gene Panel (CMPD)
  • JAK2 V617F mutation analysis - Positive or Negative
  • Calreticulin (CALR) mutation analysis - Positive or Negative
  • MPL mutation analysis - Positive or Negative
  • BCR-ABL1 fusion gene analysis - Positive or Negative
  • PDGFRA mutation analysis - Positive or Negative

What does this test Chronic Myeloproliferative Disorder Gene Panel (CMPD) identify?

  • Chronic Myeloproliferative Disorder Gene Panel (CMPD) identifies mutations in genes associated with chronic myeloproliferative disorders.
  • These disorders are characterized by the overproduction of one or more types of blood cells in the bone marrow.
  • The panel tests for mutations in genes such as JAK2, CALR, and MPL, which are commonly associated with myeloproliferative disorders.
  • Identifying mutations in these genes can help in diagnosing and monitoring the progression of chronic myeloproliferative disorders.

Why is this test Chronic Myeloproliferative Disorder Gene Panel (CMPD) taken?

Why is the Chronic Myeloproliferative Disorder Gene Panel (CMPD) taken?

The Chronic Myeloproliferative Disorder Gene Panel (CMPD) test is taken to diagnose and monitor chronic myeloproliferative disorders (CMPDs), a group of rare blood cancers that result in the overproduction of one or more types of blood cells in the bone marrow. The test analyzes specific genes associated with CMPDs, such as JAK2, CALR, and MPL, to identify mutations that may be causing the disorder.

Common CMPDs include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. By identifying genetic mutations, healthcare providers can accurately diagnose CMPDs, determine prognosis, and guide treatment decisions. The CMPD gene panel test is essential for personalized medicine approaches and ensuring patients receive the most effective treatments for their specific condition.

No FAQs available.

Customer Google Rating